POP MART
09992
XIAOMI-W
01810
BYD COMPANY
01211
4
BABA-W
09988
5
HORIZONROBOT-W
09660
HK Stock MarketDetailed Quotes
08622 HUAKANG BIOMED
- 0.355
- -0.005-1.39%
Market Closed May 2 16:08 CST
177.67MMarket Cap-39.44P/E (TTM)
0.360High0.355Low272.00KVolume0.360Open0.360Pre Close97.20KTurnover0.05%Turnover RatioLossP/E (Static)500.47MShares0.41052wk High3.03P/B177.67MFloat Cap0.08052wk Low--Dividend TTM500.47MShs Float0.540Historical High--Dividend LFY1.39%Amplitude0.080Historical Low0.357Avg Price8000Lot Size--Div YieldTTM--Div Yield LFY
HUAKANG BIOMED Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 28.09%-4.16M | ---- | -92.28%-5.78M | ---- | 22.96%-3.01M | ---- | 65.68%-3.9M | ---- | -1,828.27%-11.37M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -26.73%-512K | ---- | -0.50%-404K | ---- | -124.58%-402K | ---- | 3.24%-179K | ---- | -6.32%-185K | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40K | ---- |
| Impairment and provisions: | -102.80%-49K | ---- | 388.27%1.75M | ---- | 11.88%358K | ---- | -90.28%320K | ---- | 1,085.33%3.29M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.56M | ---- |
| -Impairment of trade receivables (reversal) | -101.93%-34K | ---- | 372.65%1.76M | ---- | -41.44%373K | ---- | -19.06%637K | ---- | 414.80%787K | ---- |
| -Other impairments and provisions | 0.00%-15K | ---- | 0.00%-15K | ---- | 95.27%-15K | ---- | -509.62%-317K | ---- | 38.10%-52K | ---- |
| Asset sale loss (gain): | 122.22%20K | ---- | --9K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 253.85%20K | ---- | ---13K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | --22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 4.88%3.33M | ---- | 1.24%3.18M | ---- | 6.48%3.14M | ---- | -7.67%2.95M | ---- | 15.64%3.19M | ---- |
| -Amortization of intangible assets | 0.00%677K | ---- | 71.83%677K | ---- | 50.96%394K | ---- | -20.91%261K | ---- | -10.81%330K | ---- |
| Financial expense | 62.26%86K | ---- | -3.64%53K | ---- | -46.08%55K | ---- | 37.84%102K | ---- | 2.78%74K | ---- |
| Special items | ---- | ---- | 356.52%210K | ---- | -75.79%46K | ---- | -92.92%190K | ---- | 89,300.00%2.68M | ---- |
| Operating profit before the change of operating capital | -29.58%-1.28M | ---- | -619.47%-987K | ---- | 136.47%190K | ---- | 77.11%-521K | ---- | -176.45%-2.28M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 238.65%678K | ---- | -146.66%-489K | ---- | 164.14%1.05M | ---- | -2,493.65%-1.63M | ---- | 84.96%-63K | ---- |
| Accounts receivable (increase)decrease | -704.62%-393K | ---- | 146.10%65K | ---- | -133.89%-141K | ---- | 113.38%416K | ---- | -409.87%-3.11M | ---- |
| Accounts payable increase (decrease) | -216.30%-2.2M | ---- | 20.40%1.89M | ---- | 630.07%1.57M | ---- | -155.95%-296K | ---- | 110.00%529K | ---- |
| Special items for working capital changes | 120.00%143K | ---- | 20.91%-715K | ---- | -3,328.57%-904K | ---- | -98.49%28K | ---- | 1,538.05%1.85M | ---- |
| Cash from business operations | -1,186.08%-3.05M | ---- | -113.45%-237K | ---- | 187.79%1.76M | ---- | 34.56%-2.01M | ---- | -89.79%-3.07M | ---- |
| Other taxs | -106.88%-13K | ---- | 139.71%189K | ---- | -31.49%-476K | ---- | 57.76%-362K | ---- | 51.69%-857K | ---- |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---9K | ---- | ---- | ---- |
| Special items of business | ---- | -7,328.21%-2.82M | ---- | 119.40%39K | ---- | 87.44%-201K | ---- | 68.13%-1.6M | ---- | 35.35%-5.02M |
| Net cash from operations | -6,277.08%-3.06M | -7,328.21%-2.82M | -103.73%-48K | 119.40%39K | 154.08%1.29M | 87.44%-201K | 39.40%-2.38M | 68.13%-1.6M | -15.75%-3.92M | 35.35%-5.02M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 87.57%347K | ---- | -53.98%185K | ---- | 124.58%402K | ---- | -3.24%179K | ---- | 6.32%185K | ---- |
| Loan receivable (increase) decrease | --2.2M | ---- | ---- | ---- | ---3.8M | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | 53.85%20K | ---- | --13K | ---- | ---- | ---- | --97K | ---- | ---- | ---- |
| Purchase of fixed assets | -32.62%-1.99M | ---- | -131.43%-1.5M | ---- | 66.74%-649K | ---- | -12.06%-1.95M | ---- | 5.48%-1.74M | ---- |
| Selling intangible assets | ---- | ---- | --151K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | 57.37%-162K | ---- | -11.76%-380K | ---- | 7.10%-340K | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---1.9M | ---- | ---- | ---- | ---40K | ---- |
| Other items in the investment business | ---- | 76.36%-122K | ---- | -175.94%-516K | ---- | -48.41%-187K | ---- | 81.95%-126K | ---- | 27.82%-698K |
| Net cash from investment operations | -283.78%-4.43M | 76.36%-122K | 81.13%-1.15M | -175.94%-516K | -197.27%-6.11M | -48.41%-187K | -6.15%-2.06M | 81.95%-126K | 4.35%-1.94M | 27.82%-698K |
| Net cash before financing | -523.31%-7.49M | -516.56%-2.94M | 75.10%-1.2M | -22.94%-477K | -8.80%-4.82M | 77.52%-388K | 24.35%-4.43M | 69.82%-1.73M | -8.24%-5.86M | 34.52%-5.72M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | 10.18%1.44M | ---- | 1,194.06%1.31M | ---- | --101K | ---- | ---- | ---- |
| Issuing shares | 1,504.71%7.49M | ---- | -79.74%467K | ---- | --2.31M | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | 2,037.36%6.9M | ---- | 14.83%-356K | ---- | 5.22%-418K | ---- | 57.14%-441K | ---- | ---1.03M |
| Net cash from financing operations | 515.54%6.3M | 2,037.36%6.9M | -55.98%1.02M | 14.83%-356K | 270.13%2.32M | 5.22%-418K | -23.40%-1.37M | 57.14%-441K | -86.36%-1.11M | ---1.03M |
| Effect of rate | -32.11%-251K | 28.05%-236K | 53.09%-190K | -53.99%-328K | -753.23%-405K | -1,026.09%-213K | -47.46%62K | 866.67%23K | 2,850.00%118K | ---3K |
| Net Cash | -567.98%-1.19M | 574.91%3.96M | 92.88%-178K | -3.35%-833K | 56.91%-2.5M | 62.81%-806K | 16.76%-5.8M | 67.89%-2.17M | -15.96%-6.97M | 22.74%-6.75M |
| Begining period cash | -1.11%32.94M | -1.11%32.94M | -8.02%33.3M | -8.02%33.3M | -13.68%36.21M | -13.68%36.21M | -14.04%41.94M | -14.04%41.94M | -10.96%48.79M | -10.96%48.79M |
| Cash at the end | -4.37%31.5M | 14.04%36.66M | -1.11%32.94M | -8.66%32.14M | -8.02%33.3M | -11.59%35.19M | -13.68%36.21M | -5.33%39.8M | -14.04%41.94M | -8.73%42.04M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.